Indeed, drugs blocking ITGAV function have been successful in preclinical mouse models of breast cancer metastasis [20,21], underscoring the importance of miR-142-3p-dependent ITGAV regulation in our in vitro system. This evidence concerns the gene ITGAV and breast carcinoma.